This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
Lawyers regularly communicate with clients who are angry, overwhelmed, frightened, unrealistic, or d...
This program provides attorneys with a foundational understanding of derivatives and their role in m...
U.S. businesses providing online services that are used by minors face a rapidly evolving patchwork ...
This course on trade secrets litigation provides real-world best practices through all key stages of...
During this course, you will learn about best practices and strategies for retaining intellectual pr...
Adverse and derogatory information often has devastating effects on a contractor's ability to win co...
This presentation serves as a critical follow-up to the June 12, 2026, session on PTAB Discretionary...
Have you felt overwhelmed by the amount of technology available to family lawyers? We'll get to know...
This course analyzes federal contractor cyber security obligations under the Federal Acquisition Reg...
This course analyzes federal contractor obligations under the Trade Agreements Act. Learn how to ens...